nedocromil has been researched along with olopatadine hydrochloride in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gamache, DA; Miller, ST; Sharif, NA; Spellman, JM; Xu, S; Yanni, JM | 1 |
| Butrus, S; Discepola, M; Finegold, I; Greiner, JV | 1 |
| Blondin, C; Cholley, B; Goldschmidt, P; Haeffner-Cavaillon, N | 1 |
| Ajayi, Y; Calder, VL; Galatowicz, G; Stern, ME | 1 |
| Ben-Eli, H; Solomon, A | 1 |
1 review(s) available for nedocromil and olopatadine hydrochloride
| Article | Year |
|---|---|
Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends.
Topics: Administration, Ophthalmic; Anti-Allergic Agents; Benzazepines; Conjunctivitis, Allergic; Cromolyn Sodium; Dibenzazepines; Histamine Antagonists; Humans; Hyperemia; Imidazoles; Ketotifen; Nedocromil; Olopatadine Hydrochloride; Phthalazines; Piperidines; Pruritus; Pyridines; Pyrimidinones | 2018 |
1 trial(s) available for nedocromil and olopatadine hydrochloride
| Article | Year |
|---|---|
Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model.
Topics: Conjunctivitis, Allergic; Dibenzoxepins; Double-Blind Method; Humans; Nedocromil; Olopatadine Hydrochloride; Ophthalmic Solutions; Patient Satisfaction; Placebos | 2000 |
3 other study(ies) available for nedocromil and olopatadine hydrochloride
| Article | Year |
|---|---|
Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells.
Topics: Administration, Topical; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Conjunctiva; Dibenzoxepins; Histamine Release; Humans; Mast Cells; Nedocromil; Olopatadine Hydrochloride; Pyridines; Pyrimidinones; Receptors, Histamine H1 | 1997 |
[In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
Topics: Air Pollutants; Anti-Allergic Agents; Benzalkonium Compounds; Benzimidazoles; Complement Activation; Conjunctivitis; Cosmetics; Dibenzoxepins; Dipeptides; Drug Evaluation; Dust; Humans; In Vitro Techniques; Ketotifen; Nedocromil; Olopatadine Hydrochloride; Ophthalmic Solutions; Oxamic Acid; Phthalazines; Piperidines; Pollen; Silicon Dioxide; Zymosan | 2003 |
Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo.
Topics: Animals; Anti-Allergic Agents; Cell Differentiation; Cell Movement; Cells, Cultured; Conjunctiva; Conjunctivitis, Allergic; Cytokines; Dibenzazepines; Dibenzoxepins; Eosinophilia; Female; Fetal Blood; Histamine Release; Humans; Imidazoles; Mast Cells; Mice; Mice, Inbred BALB C; Nedocromil; Neutrophils; Olopatadine Hydrochloride; Pollen; Proto-Oncogene Proteins c-kit; Receptors, IgE; Stem Cells | 2007 |